Results 131 to 140 of about 1,273 (144)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Archives of Toxicology, 2021
Guillermo QuintÁs, Teresa Martinez-Sena, Eugenia Pareja Ibars   +2 more
exaly  

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method

International Journal of Molecular Sciences, 2022
Rolf Teschke, Nahum Mendez-Sanchez
exaly  

A revised electronic version of RUCAM for the diagnosis of DILI

Hepatology, 2022
Paul H Hayashi, Robert J Fontana, Guruprasad P Aithal   +2 more
exaly  

Drug-induced liver injury

Nature Reviews Disease Primers, 2019
Raúl J Andrade, Naga Chalasani, Ayako Suzuki   +2 more
exaly  

Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis

Medicines (Basel, Switzerland), 2020
Rolf Teschke, Gaby Danan
exaly  

The changing epidemiology of liver diseases in the Asia–Pacific region

Nature Reviews Gastroenterology and Hepatology, 2018
Jacob George, Junjie Huang, Colette Leung   +2 more
exaly  

Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI)

Molecular Pharmaceutics, 2020
Daniel H Foil, Sean Ekins
exaly  

Landscape of DILI-related adverse drug reaction in China Mainland

Acta Pharmaceutica Sinica B, 2022
exaly  

Drug-induced liver injury: recent advances in diagnosis and risk assessment

Gut, 2017
Gerd A Kullak-Ublick, Raúl J Andrade, Andreas Benesic   +2 more
exaly  

Mechanisms of drug-induced liver injury: from bedside to bench

Nature Reviews Gastroenterology and Hepatology, 2011
Robert J Fontana
exaly